Coeptis announced a merger with Z Squared to transform into Dogecoin mining, and its stock price plummeted by nearly 40%
Coeptis Therapeutics will merge with Z Squared, a company focused on Dogecoin mining, and plans to rename itself Z Squared, officially transitioning from a biopharmaceutical company to a digital asset mining enterprise. The merger will include the acquisition of 9,000 Dogecoin mining machines and the divestment of the original biopharmaceutical department. Following this news, Coeptis' stock price plummeted by nearly 40%, with a current market value of approximately $32 million. The new company will be led by Z Squared's current CEO David Halabu and COO Michelle Burke, with the goal of creating the largest Dogecoin mining public company in the United States.
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
London-Listed Crypto Firm Vinanz Secures $4 Million to Expand U.S. Bitcoin Operations and Pursue Nasdaq Dual Listing
Vinanz, a Bitcoin-focused firm listed on the London Stock Exchange, has successfully raised $4 million in funding to accelerate its expansion into the U.S. market and explore a potential dual listing on Nasdaq. This strategic move was disclosed in a recent regulatory filing and marks a significant step in Vinanz’s growth trajectory.

Bitcoin breakout to $120K on radar as markets forget Fed July rate cut
3 reasons why Ethereum price could rally to $5,000 in 2025
Bitcoin Targets $110K Amid Institutional Inflows

Trending news
MoreCrypto prices
More








